SENOMYX AND FIRMENICH TO COLLABORATE ON COMMERCIALIZATION OF S2383, A NOVEL ENHANCER OF THE HIGH-INTENSITY SWEETENER...( - Collaboration will utilize Fi...)

- Collaboration will utilize Firmenich's world leadership in the

commercialization of flavor ingredients - New S2383 flavor enhancer may be used in beverages, foods and oral care

healthcare products to reduce the need for sucralose

SAN DIEGO, CA AND GENEVA, SWITZERLAND, November 6, 2008 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, and Firmenich SA, the world's largest privately-owned fragrance and flavor company, announced today that they have entered into a collaborative commercialization and license agreement for S2383, Senomyx's novel enhancer of the high-intensity sweetener sucralose. During the collaborative period, Firmenich will be granted exclusive rights on a worldwide basis to commercialize S2383 in virtually all product categories. Upon commercialization, Firmenich has agreed to pay Senomyx royalties on all sales of S2383 when it is sold either on a stand-alone basis or within a flavor system.

"Senomyx is extremely pleased to establish this second collaboration with Firmenich, a global leader in providing food ingredients and flavor systems to major consumer companies for use in their brands," said Kent Snyder, President and Chief Executive Officer of the Company. "After careful consideration, Senomyx determined that working with Firmenich would provide us with the best opportunity to maximize the long term revenue potential of S2383, our new sucralose enhancer. We believe that Firmenich offers key strengths in the areas of product development, proprietary formulation systems, and manufacturing that may
'/>"/>